Your browser doesn't support javascript.
loading
Serum matrix metalloproteinase-7: a potential biomarker in patients with Lynch Syndrome.
Yablecovitch, Doron; Mahajna, Hussein; Horesh, Nir; Katz, Efraim; Picard, Orit; Yavzori, Miri; Fudim, Ella; Saker, Talia; Ben-Horin, Shomron; Laish, Ido.
Afiliación
  • Yablecovitch D; Institute of Gastroenterology, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel. doronyab@gmail.com.
  • Mahajna H; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. doronyab@gmail.com.
  • Horesh N; Institute of Gastroenterology, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Katz E; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Picard O; Department of Surgery and Transplantations B/C, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Yavzori M; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Fudim E; Department of Surgery and Transplantations B/C, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Saker T; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Ben-Horin S; Institute of Gastroenterology, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Laish I; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Mol Biol Rep ; 50(9): 7471-7477, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37480510
BACKGROUND AND AIMS: The expression of tissue and serum matrix metalloproteinase-7 (MMP-7) was shown to be elevated both in colon cancer and dysplastic lesions. We aimed to evaluate, for the first time, its role as a diagnostic marker in Lynch syndrome (LS) carriers, a hereditary syndrome with predisposition to colon cancer. METHODS: This was a case control study. Baseline serum MMP-7 levels were determined by ELISA in 40 colon cancer patients, 62 LS-carriers and 60 healthy controls. Retrieved data from medical files included demographics, background diseases, clinical data regarding tumor characteristics and genetic data. We assessed the association of serum MMP-7 levels with different variables in the study cohort using linear regression model adjusted for potential confounders. RESULTS: In crude analysis, serum MMP-7 levels were significantly higher in colon cancer group compared to LS-carriers and controls [median (IQR) 4.1 ng/ml (2.7-6.0), 2.3 ng/ml (1.7-3.1), 2.5 ng/ml (1.5-3.7), respectively; p value - p < 0.001) while there was no difference between the two last groups (p value = 0.583). However, after adjusting for age and gender, LS-carriers' patients had 18% higher concentrations of serum MMP-7 compared to healthy controls (p value = 0.037), while colon cancer patients had 50% higher serum MMP-7 level in comparison to healthy controls (p value < 0.001). Additionally, age was positively associated with higher serum MMP-7 levels across all study groups (r = 0.67, p value < 0.001). In contrast, no correlation was observed between serum MMP-7 and either tumor staging and gene mutation. CONCLUSIONS: Age-adjusted serum MMP-7 levels in asymptomatic LS carriers are higher than its levels in healthy population. While in colon cancer, MMP-7 higher level probably reflects the tumor burden and may have a prognostic effect, its significance and clinical applicability as a biomarker for tumorigenesis in LS is less clear and should be elucidated.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales Hereditarias sin Poliposis / Neoplasias del Colon Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mol Biol Rep Año: 2023 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales Hereditarias sin Poliposis / Neoplasias del Colon Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mol Biol Rep Año: 2023 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Países Bajos